Por: The Hill Health April 08, 2023
The Food and Drug Administration (FDA) is pulling its approval of the only drug on the market for reducing the risk of preterm birth in pregnant women, citing a lack of effectiveness demonstrated by the treatment. The FDA approved Makena in 2011 under its accelerated approval pathway as a treatment for reducing the risk of preterm birth in women pregnant with one child and who have a history of spontaneous preterm birth. the product after a key... + full article
Orlando Sentinel USA Sports March 29, 2023
Lake Brantley 9, Seminole 6 (8 inn.) Buzz: Jackson Golden went 2-for-5 with 2 home runs and 6 RBI for Lake Brantley. Ben Colley had a home run. Bryce Carter had 2 hits for Seminole. Mount Dora Christian Academy 10, Oak Hall (Gainesville) 4 Buzz: Collin Priest went 5-for-5 with a... + más
NFL Playoff Scenarios | ABC News
Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate
Orlando Sentinel USA Sports March 25, 2023
Orangewood Christian 11, The Master’s Academy 1 Buzz: Austin Waring threw 5 innings of 1-run ball (0 earned runs) while allowing 4 hits and striking out 8 for Orangewood Christian. He lowered his season ERA to 0.78. Aiden McKee went 3-for-3 with a double, a walk, an RBI and a... + más
CNN USA Health November 15, 2022
CNN — The rate of premature birth in the United States is climbing, according to the infant and maternal health nonprofit March of Dimes. On Tuesday, the organization released its , which involves a newly updated calculation system. Taking an in-depth look at premature... + más
FDA panel recommends pulling preterm birth drug from the market | The Boston Globe
F.D.A. Panel Recommends Pulling Preterm Birth Drug From the Market | The New York Times
Time USA Life October 28, 2022
Every day, as I rush to preterm deliveries on the labor floor of my safety-net hospital and work beside incubators and clear plastic hospital bassinets, one of my patients’ mothers confides to me her belief that if she had only done that one thing differently during pregnancy,... + más
US gets D+ grade for rising preterm birth rates, new report finds | CNN
The New York Times USA Health October 20, 2022
A Food and Drug Administration advisory committee on Wednesday recommended removing the drug Makena from the market, after years of study showed the fast-tracked drug had failed to prevent preterm births.Makena has been in use for 11 years, and the panel’s vote was widely of... + más
FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth | CNBC
The Boston Globe USA Nation October 20, 2022
A Food and Drug Administration advisory committee on Wednesday recommended removing the drug Makena from the market, after years of study showed the fast-tracked drug had failed to prevent preterm birth.Makena has been in use for 11 years, and the panel’s vote was widely... + más
CNBC USA Health October 19, 2022
An advisory panel to the Food and Drug Administration voted Wednesday to take a drug intended to prevent premature births off the market, saying that it remains doubtful that the drug works.The recommendation, in a 14-1 vote, from the agency's Obstetrics, Reproductive and... + más
FDA panel backs removal of unproven pregnancy drug | WPLG Local 10
ALS drug wins FDA approval despite questionable data | ABC News
About iurex | Privacy Policy | Disclaimer |